| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $1.24 (Beat by $0.08) |
| EPS GAAP Actual | $1.24 (Beat by $0.08) |
| Revenue Actual | $3.591B |
| Revenue Surprise | Beat by $3591M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.17323 |
| EPS GAAP Estimate | $1.17323 |
| Revenue Estimate | $3.910330985B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 5.4628 | 8.22 | 5.23929 | 6.11818 | 1 |
| Dec 2028 | 6.3 | 7.13 | 6.08359 | 6.58689 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.73 | -0.38524 | 3.591B | 3.95% | -305.93M |
| FQ2 2025 (Jun 2025) | 1.04 | 1.04 | 3.638B | 0.96% | 3638M |
| FQ1 2025 (Mar 2025) | 0.72 | 0.72 | 3.515B | -2.28% | 3515M |
| FQ4 2024 (Dec 2024) | -1.85 | -1.85 | 3.439B | 45.45% | 3439M |
| FQ3 2024 (Sep 2024) | 1.05 | 1.05 | 3.449B | -5.02% | 3449M |
| FQ2 2024 (Jun 2024) | 1.34 | 1.34 | 3.603B | -25.45% | 3603M |
| FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 3.595B | -16.27% | 3595M |
| FQ4 2023 (Dec 2023) | 0.66 | 0.66 | 1.876B | -118.98% | 1876M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.17323
Consensus Revenue Estimates
3.910330985B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 1.4098 | -- | 1.4098 | 1.4098 | 8 |
| FQ3 2027 (Jul 2027) | 1.4003 | -- | 1.4003 | 1.4003 | 5 |
| FQ2 2027 (Jun 2027) | 1.5698 | -- | 1.52099 | 1.62823 | 8 |
| FQ1 2027 (Mar 2027) | 1.3184 | -- | 1.27741 | 1.36747 | 8 |
| FQ4 2026 (Oct 2026) | 1.30263 | -- | 1.24747 | 1.36788 | 7 |
| FQ3 2026 (Jul 2026) | 1.3149 | 44.48 | 1.25922 | 1.38076 | 4 |
| FQ2 2026 (Jun 2026) | 1.2251 | 15.11 | 1.15382 | 1.29999 | 4 |
| FQ1 2026 (Mar 2026) | 1.11607 | 35.49 | 1.05113 | 1.1843 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 4.35B | -- | 4.35B | 4.35B | 5 |
| FQ3 2027 (Jul 2027) | 4.43B | -- | 4.43B | 4.43B | 5 |
| FQ2 2027 (Jun 2027) | 4.53B | -- | 4.42B | 4.66B | 4 |
| FQ1 2027 (Mar 2027) | 4.32B | -- | 4.22B | 4.45B | 7 |
| FQ4 2026 (Oct 2026) | 4.15B | -- | 4.01B | 4.31B | 5 |
| FQ3 2026 (Jul 2026) | 4.2B | 14.45 | 4.06B | 4.36B | 5 |
| FQ2 2026 (Jun 2026) | 4.19B | 13.08 | 4B | 4.38B | 5 |
| FQ1 2026 (Mar 2026) | 3.98B | 11.69 | 3.8B | 4.17B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.11524 | 0.73 | -0.38524 | -52.77% |
| FQ2 2025 (Jun 2025) | 1.04 | 1.04 | 100% | |
| FQ1 2025 (Mar 2025) | 0.72 | 0.72 | 100% | |
| FQ4 2024 (Dec 2024) | -1.85 | -1.85 | 100% | |
| FQ3 2024 (Sep 2024) | 1.05 | 1.05 | 100% | |
| FQ2 2024 (Jun 2024) | 1.34 | 1.34 | 100% | |
| FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 100% | |
| FQ4 2023 (Dec 2023) | 0.66 | 0.66 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.9B | $3.59B | $-305.93M | -8.52% |
| FQ2 2025 (Jun 2025) | $0B | $3.64B | $3638M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.52B | $3515M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.44B | $3439M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.45B | $3449M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.6B | $3603M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.6B | $3595M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.88B | $1876M | 100% |